Table 1 Baseline characteristics
Smokers | 0 (0%) |
|---|---|
Hypertension | 10 (33.3%) |
Diabetes duration (years) Median (Q1-Q3) | 10 (4.75–20) |
Anti-diabetic medications | |
 Oral | 21 (70%) |
 Insulin | 9 (30%) |
 Statin therapy at enrollment | 13 (43.3%) |
 Anti-platelet therapy at enrollment | 6 (20%) |
 Total number of fasting days, Median (Q1-Q3) | 30 (30- 36) |
 eGFR (ml/min) Mean ± SD | 77.5 ± 17.8 |
Cardiovascular risk categories (ESC. 2019) | |
 Very high risk | 14 (46.7%) |
 High risk | 16 (53.3%) |